stars 1 stars 2 stars 3

ACIRNA Therapeutics is developing the next advance in RNA medicine. Building on our foundation in self-amplifying RNA, we have invented amplified circular RNA (acRNA) — a new RNA technology that unites amplification and circularization in a single platform, opening new possibilities for precision RNA programming and the development of transformative therapies across indications. We are advancing first- and best-in-class RNA therapeutics engineered to reprogram the immune system against cancer and autoimmune disease. Amplified + Circular + RNA → ACIRNA. Immunity Amplified. Formerly Chimeron Bio.

Chimeron Bio Questions

Kevin Heyeck is the CEO and Director of Chimeron Bio.

6 people are employed at Chimeron Bio.

Chimeron Bio is based in Philadelphia, Pennsylvania.

Top Chimeron Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users